{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:52:56Z","timestamp":1791910376380,"version":"4.3.4"},"reference-count":120,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118316","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:38:21Z","timestamp":1785944301000},"page":"118316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["A role for apolipoprotein E4 (ApoE4) in the pathogenesis of depressive symptoms and Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"253","author":[{"given":"Qing-Xi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7967-3456","authenticated-orcid":false,"given":"Wei","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.118316_b0005","article-title":"The selective SIK2 inhibitor ARN-3236 produces strong antidepressant-like efficacy in mice via the hippocampal CRTC1-CREB-BDNF pathway","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"9\u201310","key":"10.1016\/j.bcp.2026.118316_b0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000505132","article-title":"Lipopolysaccharide-induced depression-like behaviors is ameliorated by sodium butyrate via inhibiting neuroinflammation and oxido-nitrosative stress","volume":"105","author":"Qiu","year":"2020","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","article-title":"Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States","volume":"75","author":"Hasin","year":"2018","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bcp.2026.118316_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1398292","article-title":"A novel probiotic formula BLLL, ameliorates chronic stress-induced depression-like behaviors in mice by reducing neuroinflammation and increasing neurotrophic factors","volume":"15","author":"Ye","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118316_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155427","article-title":"Uncovering the effect and mechanism of Jiawei Xiaoyao Wan in treating breast cancer complicated with depression based on network pharmacology and experimental analysis","volume":"128","author":"Bai","year":"2024","journal-title":"Phytomedicine"},{"issue":"23","key":"10.1016\/j.bcp.2026.118316_b0030","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1111\/bph.17324","article-title":"Serotonergic transmission plays differentiated roles in the rapid and sustained antidepressant-like effects of ketamine","volume":"181","author":"Yin","year":"2024","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118316_b0035","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1177\/0271678X241237974","article-title":"The brain's \u201cdark energy\u201d puzzle: how strongly is glucose metabolism linked to resting-state brain activity?","volume":"44","author":"Volpi","year":"2024","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9","key":"10.1016\/j.bcp.2026.118316_b0040","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/jcbfm.2013.94","article-title":"Cerebral energy metabolism and the brain's functional network architecture: an integrative review","volume":"33","author":"Lord","year":"2013","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0045","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamapsychiatry.2025.1858","article-title":"The role of energy homeostasis in depression pathophysiology and its heterogeneity","volume":"82","author":"Pistis","year":"2025","journal-title":"JAMA Psychiat."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0050","doi-asserted-by":"crossref","first-page":"4138","DOI":"10.1038\/s41380-023-02098-9","article-title":"Targeting PDK2 rescues stress-induced impaired brain energy metabolism","volume":"28","author":"Wang","year":"2023","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108572","article-title":"ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism","volume":"34","author":"Qi","year":"2021","journal-title":"Cell Rep."},{"issue":"30","key":"10.1016\/j.bcp.2026.118316_b0060","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1523\/JNEUROSCI.2262-17.2018","article-title":"Human ApoE isoforms differentially modulate brain glucose and ketone body metabolism: implications for Alzheimer's disease risk reduction and early intervention","volume":"38","author":"Wu","year":"2018","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0070","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","article-title":"Alzheimer mechanisms and therapeutic strategies","volume":"148","author":"Huang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2026.118316_b0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.arr.2016.02.002","article-title":"Apolipoprotein E (APOE) \u03b54 and episodic memory decline in Alzheimer's disease: a review","volume":"27","author":"El Haj","year":"2016","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0080","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cell.2016.12.044","article-title":"ApoE2, ApoE3, and ApoE4 differentially stimulate APP transcription and A\u03b2 secretion","volume":"168","author":"Huang","year":"2017","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bcp.2026.118316_b0085","doi-asserted-by":"crossref","first-page":"8913","DOI":"10.1073\/pnas.1207022109","article-title":"Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease","volume":"109","author":"Frieden","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.immuni.2023.12.001","article-title":"An exhausted-like microglial population accumulates in aged and APOE4 genotype Alzheimer's brains","volume":"57","author":"Millet","year":"2024","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bcp.2026.118316_b0095","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"issue":"35","key":"10.1016\/j.bcp.2026.118316_b0100","doi-asserted-by":"crossref","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","article-title":"Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms","volume":"269","author":"Dong","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70795","article-title":"APOE \u03b54 linked effects on clinical features and neuropathology in dementia with Lewy bodies","volume":"21","author":"Ye","year":"2025","journal-title":"Alzheimers Dement."},{"issue":"5","key":"10.1016\/j.bcp.2026.118316_b0110","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.13879","article-title":"Associations between vascular risk factor levels and cognitive decline among stroke survivors","volume":"6","author":"Levine","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"11","key":"10.1016\/j.bcp.2026.118316_b0115","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.biopsych.2023.10.008","article-title":"Depression in Alzheimer's disease: epidemiology mechanisms, and treatment","volume":"95","author":"Huang","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.bcp.2026.118316_b0120","first-page":"3257","article-title":"Apolipoprotein E4 and late-onset Alzheimer's disease","volume":"52","author":"Tamaoka","year":"1994","journal-title":"Nihon Rinsho"},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0125","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.plipres.2010.09.001","article-title":"Apolipoprotein E: from lipid transport to neurobiology","volume":"50","author":"Hauser","year":"2011","journal-title":"Prog. Lipid Res."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0130","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1038\/s41467-020-19264-0","article-title":"APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids","volume":"11","author":"Zhao","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.bcp.2026.118316_b0135","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00109-016-1427-y","article-title":"Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders","volume":"94","author":"Mahley","year":"2016","journal-title":"J. Mol. Med. (Berl)"},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0140","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.1997.03540340056033","article-title":"Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons","volume":"277","author":"Evans","year":"1997","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.3233\/JAD-181089","article-title":"Putative survival advantages in young apolipoprotein \u025b4 carriers are associated with increased neural stress","volume":"68","author":"Smith","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"8","key":"10.1016\/j.bcp.2026.118316_b0150","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0022-2275(20)42621-5","article-title":"Apolipoprotein E distribution among human plasma lipoproteins: role of the cysteine-arginine interchange at residue 112","volume":"31","author":"Weisgraber","year":"1990","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0155","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI112645","article-title":"Abnormal in vivo metabolism of apolipoprotein E4 in humans","volume":"78","author":"Gregg","year":"1986","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2026.118316_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2026.103153","article-title":"Apolipoprotein E4 and synaptic dysfunction in Alzheimer's disease: mechanisms and therapeutic implications","volume":"119","author":"Yao","year":"2026","journal-title":"Ageing Res. Rev."},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0165","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006312","article-title":"Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease","volume":"2","author":"Holtzman","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"15","key":"10.1016\/j.bcp.2026.118316_b0170","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","article-title":"Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms","volume":"109","author":"Shi","year":"2021","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bcp.2026.118316_b0175","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/s41593-022-01127-0","article-title":"Peripheral apoE4 enhances Alzheimer's pathology and impairs cognition by compromising cerebrovascular function","volume":"25","author":"Liu","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0180","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41419-022-04858-x","article-title":"Ageing related thyroid deficiency increases brain-targeted transport of liver-derived ApoE4-laden exosomes leading to cognitive impairment","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0185","doi-asserted-by":"crossref","first-page":"E322","DOI":"10.1152\/ajpendo.00408.2004","article-title":"apoE4 allele and the natural history of cardiovascular risk factors","volume":"289","author":"Scuteri","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0190","doi-asserted-by":"crossref","first-page":"259","DOI":"10.14336\/AD.2023.0530","article-title":"Human APOE4 protects high-fat and high-sucrose diet fed targeted replacement mice against fatty liver disease compared to APOE3","volume":"15","author":"Huebbe","year":"2024","journal-title":"Aging Dis."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0195","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1093\/brain\/awab478","article-title":"APOE4 derived from astrocytes leads to blood-brain barrier impairment","volume":"145","author":"Jackson","year":"2022","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.bcp.2026.118316_b0200","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","article-title":"Cholesterol and matrisome pathways dysregulated in astrocytes and microglia","volume":"185","author":"Tcw","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0205","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41398-021-01631-0","article-title":"APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline","volume":"11","author":"Fang","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0210","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1038\/s41591-024-03122-3","article-title":"Sex-dependent APOE4 neutrophil-microglia interactions drive cognitive impairment in Alzheimer's disease","volume":"30","author":"Rosenzweig","year":"2024","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13024-023-00620-9","article-title":"Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer's Disease drug candidate","volume":"18","author":"Nemergut","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2026.118316_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173803","article-title":"A comprehensive understanding about the pharmacological effect of diallyl disulfide other than its anti-carcinogenic activities","volume":"893","author":"He","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118316_b0225","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.898955","article-title":"A review for the pharmacological effects of paeoniflorin in the nervous system","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118316_b0230","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.829966","article-title":"Indole-3-carbinol selectively prevents chronic stress-induced depression-but not anxiety-like behaviors via suppressing pro-inflammatory cytokine production and oxido-nitrosative stress in the brain","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118316_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115466","article-title":"GRP78 alleviates secondary brain injury by regulating phenotype polarization in astrocytes via JAK2-STAT3 pathway after intracerebral hemorrhage","volume":"165","author":"Yang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2026.118316_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115494","article-title":"The immunoregulator \u03b2-glucan produces antidepressant effects through microglia-mobilized astrocytic P2Y1R-BDNF signaling in the dentate gyrus","volume":"165","author":"Song","year":"2025","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.stem.2024.10.005","article-title":"Microglia depletion reduces human neuronal APOE4-related pathologies in a chimeric Alzheimer's disease model","volume":"32","author":"Rao","year":"2025","journal-title":"Cell Stem Cell"},{"issue":"37","key":"10.1016\/j.bcp.2026.118316_b0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2516103122","article-title":"Microglia-to-neuron signaling links APOE4 and inflammation to enhanced neuronal lipid metabolism and network activity","volume":"122","author":"Verduzco Espinoza","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.bcp.2026.118316_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111200","article-title":"APOE4 drives inflammation in human astrocytes via TAGLN3 repression and NF-\u03baB activation","volume":"40","author":"Arnaud","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bcp.2026.118316_b0260","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6634181","article-title":"Low-dose copper exposure exacerbates depression-like behavior in ApoE4 transgenic mice","volume":"2021","author":"Xu","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13195-023-01330-6","article-title":"A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice","volume":"15","author":"Balu","year":"2023","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.bcp.2026.118316_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155298","article-title":"A new andrographolide derivative ADA targeting SIRT3-FOXO3a signaling mitigates cognitive impairment by activating mitophagy and inhibiting neuroinflammation in Apoe4 mice","volume":"124","author":"Zhou","year":"2024","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.bcp.2026.118316_b0275","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18160","article-title":"ApoE4 dysregulation incites depressive symptoms and mitochondrial impairments in mice","volume":"28","author":"Li","year":"2024","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2026.118316_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120759","article-title":"Polygalae Radix extracts show anti-Parkinson's disease effects and reduce depression-like symptoms by modulating energy metabolism","volume":"356","author":"Jiao","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118316_b0285","doi-asserted-by":"crossref","first-page":"14167","DOI":"10.1007\/s12035-025-05222-8","article-title":"Elevated acetylation of MFN2 is accompanied by the disruption of mitochondrial energy metabolism and inflammation in a mouse model of depression","volume":"62","author":"Xie","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"51","key":"10.1016\/j.bcp.2026.118316_b0290","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","article-title":"Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity","volume":"102","author":"Chang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.bcp.2026.118316_b0295","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3233\/JAD-190419","article-title":"Neuron-specific apolipoprotein E4 (1-272) fragment induces tau hyperphosphorylation and axonopathy via triggering endoplasmic reticulum stress","volume":"71","author":"Liang","year":"2019","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0305","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13293-025-00684-w","article-title":"Sex differences in cognition, anxiety-phenotype and therapeutic effect of metformin in the aged apoE-TR mice","volume":"16","author":"Lin","year":"2025","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.bcp.2026.118316_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.113772","article-title":"Metformin alleviates the depression-like behaviors of elderly apoE4 mice via improving glucose metabolism and mitochondrial biogenesis","volume":"423","author":"Lin","year":"2022","journal-title":"Behav. Brain Res."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0315","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/gps.5583","article-title":"Trajectories of depression symptoms over time differ by APOE4 genotype in older adults with type 2 diabetes","volume":"36","author":"Lavie","year":"2021","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0320","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061488","article-title":"5-HT3 antagonist ondansetron increases apoE secretion by modulating the LXR-ABCA1 pathway","volume":"20","author":"Shinohara","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0325","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","article-title":"Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist","volume":"112","author":"Litvinchuk","year":"2024","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0330","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.immuni.2023.02.002","article-title":"Lipopolysaccharide-binding protein expression is increased by stress and inhibits monoamine synthesis to promote depressive symptoms","volume":"56","author":"Fang","year":"2023","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0335","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/1381612825666190312102444","article-title":"Novel pathways in the treatment of major depression: focus on the glutamatergic system","volume":"25","author":"Tomasetti","year":"2019","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.bcp.2026.118316_b0340","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABA(A) receptors as targets for treating affective and cognitive symptoms of depression","volume":"44","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0345","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1073858402238515","article-title":"GABA and glutamate in the human brain","volume":"8","author":"Petroff","year":"2002","journal-title":"Neuroscientist"},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0350","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/nsmb1228","article-title":"GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop","volume":"14","author":"Fenalti","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0355","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13024-016-0107-2","article-title":"Early-life stress leads to impaired spatial learning and memory in middle-aged ApoE4-TR mice","volume":"11","author":"Lin","year":"2016","journal-title":"Mol. Neurodegener."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0360","doi-asserted-by":"crossref","DOI":"10.3390\/biom10060964","article-title":"Reelin functions, mechanisms of action and signaling pathways during brain development and maturation","volume":"10","author":"Jossin","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.118316_b0365","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jpsychires.2021.09.029","article-title":"ApoE4 increases susceptibility to stress-induced age-dependent depression-like behavior and cognitive impairment","volume":"143","author":"Zhang","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0370","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","article-title":"GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice","volume":"5","author":"Li","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0375","article-title":"Evidence against altered excitatory\/inhibitory balance in the posteromedial cortex of young adult APOE E4 carriers: a resting state (1)H-MRS study","volume":"1","author":"Costigan","year":"2021","journal-title":"Neuroimage Rep"},{"issue":"1906","key":"10.1016\/j.bcp.2026.118316_b0380","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2023.0229","article-title":"Interplay of hippocampal long-term potentiation and long-term depression in enabling memory representations","volume":"379","author":"Hagena","year":"2024","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115743","article-title":"Bioactive ketamine metabolite exerts in vivo neuroplastogenic effects to improve hippocampal function in a treatment-resistant depression model","volume":"44","author":"Riggs","year":"2025","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0390","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.bbr.2008.05.008","article-title":"Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks","volume":"193","author":"Bour","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.bcp.2026.118316_b0395","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1146\/annurev.genet.36.062802.091007","article-title":"Genetic approaches to molecular and cellular cognition: a focus on LTP and learning and memory","volume":"36","author":"Matynia","year":"2002","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.bcp.2026.118316_b0400","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neulet.2017.03.043","article-title":"Co-injection of A\u03b21-40 and ApoE4 impaired spatial memory and hippocampal long-term potentiation in rats","volume":"648","author":"Wu","year":"2017","journal-title":"Neurosci. Lett."},{"issue":"12","key":"10.1016\/j.bcp.2026.118316_b0405","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hipo.20357","article-title":"Estradiol enhances long term potentiation in hippocampal slices from aged apoE4-TR mice","volume":"17","author":"Yun","year":"2007","journal-title":"Hippocampus"},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0410","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/jnr.20684","article-title":"Blockade of nicotinic acetylcholine receptors suppresses hippocampal long-term potentiation in wild-type but not ApoE4 targeted replacement mice","volume":"82","author":"Yun","year":"2005","journal-title":"J. Neurosci. Res."},{"issue":"26","key":"10.1016\/j.bcp.2026.118316_b0415","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0914984107","article-title":"ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling","volume":"107","author":"Chen","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bcp.2026.118316_b0420","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fncel.2016.00089","article-title":"Epigenetic RELN dysfunction in schizophrenia and related neuropsychiatric disorders","volume":"10","author":"Guidotti","year":"2016","journal-title":"Front. Cell. Neurosci."},{"issue":"42","key":"10.1016\/j.bcp.2026.118316_b0425","doi-asserted-by":"crossref","first-page":"39944","DOI":"10.1074\/jbc.M205147200","article-title":"Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning","volume":"277","author":"Weeber","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0430","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neuron.2005.07.007","article-title":"Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2","volume":"47","author":"Beffert","year":"2005","journal-title":"Neuron"},{"issue":"7","key":"10.1016\/j.bcp.2026.118316_b0435","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1176\/ajp.156.7.1000","article-title":"Recurrence after recovery from major depressive disorder during 15 years of observational follow-up","volume":"156","author":"Mueller","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bcp.2026.118316_b0440","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1192\/bjp.153.6.741","article-title":"The long-term outcome of Maudsley depressives","volume":"153","author":"Lee","year":"1988","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bcp.2026.118316_b0445","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jad.2021.08.089","article-title":"Apolipoprotein E4 increases the risk of depression recurrence","volume":"295","author":"Obinata","year":"2021","journal-title":"J. Affect. Disord."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0450","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/gps.2643","article-title":"Depression in mild dementia: associations with diagnosis, APOE genotype and clinical features","volume":"26","author":"Fritze","year":"2011","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0455","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.neuroimage.2008.10.010","article-title":"APOE related hippocampal shape alteration in geriatric depression","volume":"44","author":"Qiu","year":"2009","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0460","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.neulet.2009.03.007","article-title":"Resolving the relationship between ApolipoproteinE and depression","volume":"455","author":"Slifer","year":"2009","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0465","first-page":"135","article-title":"APOE4 allele in north Indian elderly patients with dementia or late onset depression-a multiple-disease case control study","volume":"8","author":"Misra","year":"2019","journal-title":"Mol Biol Res Commun"},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0470","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s40200-023-01271-9","article-title":"Association of the APOE gene variants with depression in type 2 diabetes","volume":"22","author":"Nickhah Klashami","year":"2023","journal-title":"J. Diabetes Metab. Disord."},{"issue":"6","key":"10.1016\/j.bcp.2026.118316_b0475","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2174\/1567205010666131119232444","article-title":"Involvement of the Apoer2 and Lrp1 receptors in mediating the pathological effects of ApoE4 in vivo","volume":"11","author":"Gilat-Frenkel","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"19","key":"10.1016\/j.bcp.2026.118316_b0480","doi-asserted-by":"crossref","first-page":"7538","DOI":"10.1523\/JNEUROSCI.0260-15.2015","article-title":"ApoE4 and A\u03b2 oligomers reduce BDNF expression via HDAC nuclear translocation","volume":"35","author":"Sen","year":"2015","journal-title":"J. Neurosci."},{"issue":"42","key":"10.1016\/j.bcp.2026.118316_b0485","doi-asserted-by":"crossref","first-page":"8686","DOI":"10.1523\/JNEUROSCI.0435-21.2021","article-title":"APOE4 affects basal and NMDAR-mediated protein synthesis in neurons by perturbing calcium homeostasis","volume":"41","author":"Ramakrishna","year":"2021","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0490","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2174\/1567205016666190228120254","article-title":"The role of MAPK's signaling in mediating ApoE4-driven pathology in vivo","volume":"16","author":"Salomon-Zimri","year":"2019","journal-title":"Curr. Alzheimer Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0495","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41583-023-00776-9","article-title":"Cell type-specific roles of APOE4 in Alzheimer disease","volume":"25","author":"Blumenfeld","year":"2024","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bcp.2026.118316_b0500","doi-asserted-by":"crossref","unstructured":"B. Teter, Life-span influences of apoE4 on CNS function, Neurobiol Aging 28(5) (2007) 693-703; discussion 704-6.","DOI":"10.1016\/j.neurobiolaging.2006.06.028"},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0505","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41398-021-01721-z","article-title":"Correction to: APOE4 genotype exacerbates the depression-like behavior of mice during aging through ATP decline","volume":"11","author":"Fang","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.bcp.2026.118316_b0510","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13024-023-00610-x","article-title":"Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy","volume":"18","author":"Xiong","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.bcp.2026.118316_b0515","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"structure and function in lipid metabolism, neurobiology, and Alzheimer's diseases","author":"Huang","year":"2014","journal-title":"Neurobiol Dis 72 Pt A"},{"issue":"8","key":"10.1016\/j.bcp.2026.118316_b0520","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tibs.2006.06.008","article-title":"Apolipoprotein E structure: insights into function","volume":"31","author":"Hatters","year":"2006","journal-title":"Trends Biochem. Sci"},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0525","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1007\/s12035-024-04088-6","article-title":"Andrographolide improves ApoE4-mediated blood-brain barrier injury by alleviating inflammation","volume":"61","author":"Zhou","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.118316_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.jad.2026.121224","article-title":"Neuro-immune, metabolic, and oxidative pathways in depression due to hypothyroidism and Hashimoto's thyroiditis","volume":"402","author":"Al-Baldawi","year":"2026","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2026.118316_b0535","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.bbi.2019.04.032","article-title":"Interferon-alpha-induced depression: comparisons between early- and late-onset subgroups and with patients with major depressive disorder","volume":"80","author":"Su","year":"2019","journal-title":"Brain Behav. Immun."},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0540","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/JGP.0b013e3180f63373","article-title":"ApoE4 allele is associated with late-life depression: a population-based study","volume":"15","author":"Yen","year":"2007","journal-title":"Am. J. Geriatr. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2026.118316_b0545","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gps.3803","article-title":"ApoE4 is not associated with depression when mild cognitive impairment is considered","volume":"28","author":"Nose","year":"2013","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0550","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/gps.4339","article-title":"Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease","volume":"31","author":"Qiu","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0555","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ame2.12446","article-title":"Apolipoprotein E4 interferes with lipid metabolism to exacerbate depression-like behaviors in 5xFAD mice","volume":"7","author":"Gong","year":"2024","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.bcp.2026.118316_b0560","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnagi.2020.00150","article-title":"APOE alleles and diet in brain aging and Alzheimer's disease","volume":"12","author":"Yassine","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.bcp.2026.118316_b0565","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68231","article-title":"APOE4 is associated with elevated blood lipids and lower levels of innate immune biomarkers in a tropical Amerindian subsistence population","volume":"10","author":"Garcia","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2026.118316_b0570","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jad.2016.07.033","article-title":"Depression and serum low-density lipoprotein: a systematic review and meta-analysis","volume":"206","author":"Persons","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.bcp.2026.118316_b0575","doi-asserted-by":"crossref","unstructured":"K.R. Karan, S. Andrzejewski, K.M. Stiles, N.R. Hackett, R.G. Crystal, Suppression of CNS APOE4 Expression by miRNAs Delivered by the S2 AAVrh.10 Capsid-Modified Vector, Hum Gene Ther 35) (2024.","DOI":"10.1089\/hum.2024.112"},{"issue":"23","key":"10.1016\/j.bcp.2026.118316_b0580","article-title":"Loss of endothelial APOE4 dysregulates neural function in vivo","volume":"13","author":"Marottoli","year":"2024","journal-title":"J. Am. Heart Assoc."},{"issue":"18","key":"10.1016\/j.bcp.2026.118316_b0585","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1021\/acs.biochem.6b00324","article-title":"ApoE: in vitro studies of a small molecule effector","volume":"55","author":"Mondal","year":"2016","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bcp.2026.118316_b0590","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.neurobiolaging.2006.02.015","article-title":"Targeting soluble Abeta peptide with Tramiprosate for the treatment of brain amyloidosis","volume":"28","author":"Gervais","year":"2007","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.bcp.2026.118316_b0595","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1212\/01.wnl.0000244346.08950.64","article-title":"A phase II study targeting amyloid-beta with 3APS in mild-to-moderate Alzheimer disease","volume":"67","author":"Aisen","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.bcp.2026.118316_b0600","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40262-017-0608-3","article-title":"Clinical pharmacokinetics and safety of ALZ-801, a novel prodrug of tramiprosate in development for the treatment of Alzheimer's disease","volume":"57","author":"Hey","year":"2018","journal-title":"Clin. Pharmacokinet."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:24:08Z","timestamp":1791908648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":120,"alternative-id":["S0006295226006556"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118316","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A role for apolipoprotein E4 (ApoE4) in the pathogenesis of depressive symptoms and Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118316"}}